BR100 Decreased By (-0.4%)
BR30 Decreased By (-0.65%)
KSE100 Decreased By (-0.29%)
KSE30 Decreased By (-0.22%)
AGHA 6.56 Decreased By ▼ -0.11 (-1.65%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.89 Decreased By ▼ -0.28 (-0.5%)
BOP 30.05 Decreased By ▼ -0.07 (-0.23%)
CNERGY 12.75 Decreased By ▼ -0.23 (-1.77%)
CSIL 5.21 Decreased By ▼ -0.10 (-1.88%)
FCCL 51.00 Decreased By ▼ -0.65 (-1.26%)
FFL 14.43 Decreased By ▼ -0.06 (-0.41%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 5.97 Decreased By ▼ -0.09 (-1.49%)
KOSM 5.58 Decreased By ▼ -0.26 (-4.45%)
LOTCHEM 26.15 Decreased By ▼ -0.02 (-0.08%)
MLCF 90.33 Decreased By ▼ -0.90 (-0.99%)
NBP 161.45 Decreased By ▼ -2.74 (-1.67%)
NCPL 52.55 Decreased By ▼ -0.63 (-1.18%)
NPL 57.98 Decreased By ▼ -1.14 (-1.93%)
OGDC 315.40 Increased By ▲ 2.01 (0.64%)
PACE 9.70 Decreased By ▼ -0.07 (-0.72%)
PAEL 34.73 Decreased By ▼ -0.51 (-1.45%)
PIBTL 14.23 Decreased By ▼ -0.48 (-3.26%)
PPL 221.00 Decreased By ▼ -0.36 (-0.16%)
PRL 90.89 Decreased By ▼ -0.33 (-0.36%)
PTC 59.25 Increased By ▲ 0.06 (0.1%)
SSGC 23.39 Increased By ▲ 0.09 (0.39%)
TBL 8.65 Decreased By ▼ -0.10 (-1.14%)
TELE 7.40 Decreased By ▼ -0.21 (-2.76%)
TPL 21.00 Decreased By ▼ -1.03 (-4.68%)
TPLP 12.02 Decreased By ▼ -0.54 (-4.3%)
TREET 21.33 Decreased By ▼ -0.40 (-1.84%)
TRG 54.35 Decreased By ▼ -1.44 (-2.58%)
Opinion Print edition: 2021-12-12

Branded vs. generic name drugs—II

Published Updated

It is not at all that prescribing the drugs by their market names is wrong. There is something to think about the fact whether it would be more transparent and in the benefits of the patients to write the drugs by the brand names. There are plenty of renowned pharmaceutical companies that charge the costly and hefty amount for the same drug which the other new smaller scale pharmaceutical companies are selling for less. The point is that why there is a difference in drugs when the same chemical is being sold in different packings.

Since the issue we are discussing is very delicate and believe the whole pharmaceutical world would defend writing the medicines by the brand names. After all, for the pharmaceutical companies, it is their business. However, I am more concerned with the poor patients who have to run after the costly medicines just because their medical doctor has prescribed the brand name. I wish, there was a system to write the generic names to make it more cost-effective and time-effective for the poor and needy patients.

(Concluded)

Dr. Batool Hassan

B.Sc., BS (US), MBBS, PGD HCM, CHQP, RMP.

Email [email protected]

Copyright Business Recorder, 2021

Dr Batool Hassan

The author is a registered medical practitioner, specialising in healthcare quality, clinical research, public health, and hospital administration. She can be reached at [email protected]

Comments

Comments are closed for this article.